![]() |
市場調查報告書
商品編碼
1949528
微孔盤系統市場 - 全球產業規模、佔有率、趨勢、機會及預測(按產品、應用、最終用戶、地區和競爭格局分類),2021-2031年Microplate Systems Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End User, By Region & Competition, 2021-2031F |
||||||
全球微孔盤系統市場預計將從 2025 年的 26.7 億美元成長到 2031 年的 37.4 億美元,複合年成長率為 5.76%。
這些系統由洗板機、讀數儀和自動化處理設備等實驗室設備組成,對於分析高密度多孔板樣品至關重要。推動其發展的主要因素是藥物研發中對高通量篩檢日益成長的需求以及基因組研究的不斷擴展,而生物製藥行業的巨額投資也為此提供了支持。例如,歐洲製藥工業協會聯合會 (EFPIA) 估計,到 2024 年,歐洲以研發為基礎的製藥業將在研發方面投入 550 億歐元,這凸顯了該產業對高效分析技術在最佳化工作流程方面的高度依賴。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 26.7億美元 |
| 市場規模:2031年 | 37.4億美元 |
| 複合年成長率:2026-2031年 | 5.76% |
| 成長最快的細分市場 | 微孔盤讀數儀 |
| 最大的市場 | 北美洲 |
然而,由於部署自動化設備需要大量資金投入,市場面臨許多障礙。購買和維護整合機器人系統和多模式讀取器的高昂成本,對於預算有限的學術機構和小規模實驗室而言,無疑是一大難題。這一經濟障礙限制了全自動解決方案的廣泛應用,迫使許多機構依賴吞吐量較低的半自動或手動替代方案。因此,成本敏感性仍然是一個重要的阻礙因素,阻礙了這些先進系統進一步滲透到資源有限的研究環境中。
製藥和生物技術領域研發投入的不斷成長是全球微孔盤系統市場的主要驅動力。由於實驗室需要篩檢龐大的化合物庫,因此越來越依賴基於微孔盤的檢測方法來識別候選治療藥物,這需要對先進的分析工具和技術進行大量投資。根據賽默飛世爾科技公司於2025年4月發布的2024年度報告,該公司將投入14億美元用於研發,以促進生命科學領域的創新,凸顯了高效檢測平台的緊迫性。此外,丹納赫公司在2025年公佈的2024年全年銷售額為239億美元,反映了利用這些高密度微孔板技術的生命科學和診斷解決方案的巨大規模。
此外,對工作流程效率和實驗室自動化日益成長的需求正在加速整合式微孔盤系統的應用。實驗室擴大採用全自動解決方案來減少人為錯誤並最大限度地提高通量,這一轉變也體現在專注於自動化工作流程和實驗室服務的行業收入的成長上。例如,安捷倫科技公司在其2024年11月發布的「2024會計年度第四季」財務報告中指出,其安捷倫CrossLab集團全年營收達到16.4億美元(年增5%)。這一成長顯示了業界對效率的追求,也證實了微孔盤技術在競爭激烈的環境中繼續發揮至關重要的作用,能夠幫助企業實現所需的精確度和速度。
全球微孔盤系統市場成長的主要障礙之一是自動化設備所需的大量資本投入。機器人液體處理設備和高效能多功能讀板機價格昂貴,往往超出學術機構和中小型生物技術公司的預算。這種資金限制迫使注重成本的企業依賴半自動化或手動工作流程,而這些流程本身就限制了營運效率和吞吐量。因此,採用完全整合解決方案主要局限於資金雄厚的製藥公司,這使得很大一部分潛在用戶無法升級到先進的自動化平台。
公共研究領域資金停滯不前,進一步加劇了新技術推廣應用的障礙。美國科學促進會宣布,美國國立衛生研究院2024年的常規預算為471億美元,這一數字反映了通貨膨脹導致的實際購買力停滯不前。預算限制迫使研究機構延遲資本密集型設備的採購。這種財政保守主義減緩了舊有系統的更新換代速度,並抑制了資源受限研究領域的整體市場成長。
將人工智慧 (AI) 整合到微孔盤分析軟體中,透過自動化量化複雜的表現型結果,正在革新數據解讀方式。為了管理高內涵篩檢資料集,實驗室正在利用機器學習演算法,從而消除人工檢驗的瓶頸,並提高檢測結果的可重複性。這項技術變革得益於旨在管理資料密集型工作流程的專用資訊學解決方案的快速普及。 2024 年 11 月,Revvity 在投資者日上宣布,其純 SaaS 軟體平台 Signals 的年度經常性收入複合年成長率 (CAGR) 已達到 12%,凸顯了現代實驗室對智慧數據工具日益成長的需求。
同時,微孔盤系統在個人化醫療工作流程中的應用日益廣泛,其應用範圍已從上游研究顯著轉向下游臨床診斷。臨床檢查室正利用多孔板進行生物標記檢驗和大規模基因測序,這對於基於特定分子譜的患者分層至關重要。這種向診斷領域的拓展帶來了穩定的收入來源,使其不受研發預算波動的影響,並得益於精準醫療對常規檢測的需求。根據Bio-Rad Laboratories於2025年2月發布的“2024會計年度第四季及全年財務業績報告”,臨床診斷部門全年淨銷售額為15.4億美元,年增3.7%。這一成長主要歸功於臨床環境中檢測產品和耗材需求的增加。
The Global Microplate Systems Market is projected to expand from USD 2.67 Billion in 2025 to USD 3.74 Billion by 2031, registering a CAGR of 5.76%. Comprising laboratory tools such as washers, readers, and automated handlers, these systems are essential for analyzing high-density multi-well samples. Growth is largely fueled by the rising need for high-throughput screening in drug discovery and the expanding applications of genomic research, supported by heavy investment from the biopharmaceutical industry. For instance, the European Federation of Pharmaceutical Industries and Associations estimated that the research-based pharmaceutical sector in Europe invested €55,000 million in research and development during 2024, highlighting the industry's dependence on efficient analytical technologies to optimize workflows.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 2.67 Billion |
| Market Size 2031 | USD 3.74 Billion |
| CAGR 2026-2031 | 5.76% |
| Fastest Growing Segment | Microplate Reader |
| Largest Market | North America |
However, the market faces a significant obstacle due to the substantial capital costs required for automated instrumentation. The high price of purchasing and maintaining integrated robotic systems and multi-mode readers can be prohibitive for academic institutions and smaller laboratories with restricted budgets. This financial hurdle limits the widespread uptake of fully automated solutions, forcing many facilities to depend on semi-automated or manual alternatives that yield lower throughput. As a result, cost sensitivity continues to be a major restraint, hindering the deeper penetration of these advanced systems into resource-limited research settings.
Market Driver
The escalating expenditure on pharmaceutical and biotechnology R&D serves as the main engine driving the Global Microplate Systems Market. As laboratories are tasked with screening immense compound libraries, there is a heightened dependence on microplate-based assays for identifying therapeutic candidates, which necessitates advanced analytical tools and substantial financial investment in technology. According to Thermo Fisher Scientific's '2024 Annual Report' released in April 2025, the company allocated $1.4 billion to research and development to foster innovation within its life sciences division, demonstrating the urgent need for efficient detection platforms. Furthermore, Danaher Corporation reported full-year 2024 revenues of $23.9 billion in 2025, reflecting the vast scale of life science and diagnostic solutions that utilize these high-density formats.
Additionally, the rising demand for improved workflow efficiency and laboratory automation is fast-tracking the uptake of integrated microplate systems. To reduce human error and maximize throughput, laboratories are increasingly adopting fully robotic solutions, a shift reflected in the growing revenues of sectors focused on automated workflows and laboratory services. For example, Agilent Technologies reported in November 2024, within its 'Fourth-Quarter Fiscal Year 2024 Financial Results', that the Agilent CrossLab Group achieved full-year revenue of $1.64 billion, a 5% increase year-over-year. This growth underscores the industry's move toward streamlined operations, ensuring microplate technologies remain fundamental to attaining the precision and speed needed in competitive research environments.
Market Challenge
A major barrier to the growth of the global microplate systems market is the significant capital expenditure necessary for automated instrumentation. Robotic liquid handlers and high-performance multi-mode readers come with premium price tags that frequently exceed the available budgets of academic institutions and small-to-medium-sized biotechnology companies. This financial limitation forces cost-conscious environments to rely on semi-automated or manual workflows, which inherently restricts operational efficiency and throughput capacity. Consequently, the deployment of fully integrated solutions is largely limited to well-funded pharmaceutical organizations, preventing a large segment of potential users from upgrading to advanced automated platforms.
This adoption hurdle is further exacerbated by stagnant funding levels within the public research domain. In 2024, the American Association for the Advancement of Science noted that regular appropriations for the National Institutes of Health were finalized at $47.1 billion, a figure representing stagnant real purchasing power due to inflation. Such budgetary restrictions compel research facilities to delay purchasing capital-intensive equipment. This fiscal conservatism retards the replacement cycle for legacy systems and impedes overall market growth within resource-constrained research sectors.
Market Trends
The incorporation of artificial intelligence into microplate analysis software is transforming data interpretation by automating the quantification of complex phenotypic results. To manage high-content screening datasets, research facilities are utilizing machine learning algorithms, which eliminate manual verification bottlenecks and improve the reproducibility of assay outcomes. This technological shift is supported by the strong uptake of specialized informatics solutions designed to manage data-intensive workflows. In November 2024, during its 'Investor Day', Revvity reported a 12% compound annual growth rate in Annual Recurring Revenue for its SaaS-only Signals software platform, highlighting the growing necessity for intelligent data tools in modern laboratories.
Concurrently, microplate systems are extending their reach into personalized medicine workflows, shifting significantly from upstream research to downstream clinical diagnostics. Clinical labs are utilizing multi-well formats for biomarker validation and large-scale genomic sequencing, which are crucial for stratifying patients based on specific molecular profiles. This expansion into the diagnostic realm generates a stable revenue stream separate from fluctuating R&D budgets, driven by the routine testing requirements of precision healthcare. As reported by Bio-Rad Laboratories in February 2025 within its 'Fourth-Quarter and Full-Year 2024 Financial Results', the Clinical Diagnostics segment achieved full-year net sales of $1.54 billion, a 3.7% rise largely credited to increased consumption of testing products and consumables in clinical settings.
Report Scope
In this report, the Global Microplate Systems Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Microplate Systems Market.
Global Microplate Systems Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: